Potential benefit of high-dose intravenous vitamin C for coronavirus disease 2019 pneumonia.
10.1097/CM9.0000000000001746
- Author:
Bing ZHAO
1
;
Mengjiao LI
1
;
Yun LING
2
;
Yibing PENG
3
;
Jun HUANG
4
;
Hongping QU
5
;
Yuan GAO
6
;
Yingchuan LI
7
;
Bijie HU
8
;
Shuihua LU
9
;
Hongzhou LU
2
;
Wenhong ZHANG
10
;
Enqiang MAO
1
Author Information
1. Department of Emergency, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
2. Department of Infectious Disease, Shanghai Public Health Clinical Center, Shanghai 201508, China.
3. Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.
4. Shanghai Institute of Hypertension, Shanghai 200025, China.
5. Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
6. Department of Critical Care Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200217, China.
7. Department of Critical Care Medicine, The Sixth People's Hospital, Shanghai Jiao Tong University, Shanghai 200233, China.
8. Department of Infectious Disease, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
9. Tuberculosis Department of Shanghai Public Health Clinical Center, Shanghai 201508, China.
10. Department of Infectious Disease of Shanghai Huashan Hospital, Fudan University, Shanghai 200040, China.
- Publication Type:Journal Article
- MeSH:
Administration, Intravenous;
Ascorbic Acid/therapeutic use*;
COVID-19;
Humans;
Pneumonia;
SARS-CoV-2
- From:
Chinese Medical Journal
2021;135(1):23-25
- CountryChina
- Language:English
